A

Atara Biotherapeutics
D

ATRA

14.070
USD
0.76
(5.71%)
مغلق
حجم التداول
696
الربح لكل سهم
3
العائد الربحي
-
P/E
20
حجم السوق
98,814,060
أصول ذات صلة الأخبار المقالات

العنوان: Atara Biotherapeutics Inc.

القطاع: Healthcare
الصناعة: Biotechnology
Atara Biotherapeutics Inc operates in the United States healthcare sector. It focuses on developing transformative therapies for patients with serious diseases, including solid tumors, hematologic cancers, and autoimmune diseases. It operates and manages business as one operating and reportable segment which is the business of developing therapeutics. The company's product candidates comprise Tab-cel, ATA188, and ATA3219 (CAR T Platform).